Catalyst Pharmaceuticals (CPRX) News Today $20.54 -0.05 (-0.24%) Closing price 04:00 PM EasternExtended Trading$20.67 +0.13 (+0.63%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CPRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Rafferty Asset Management LLC Sells 12,393 Shares of Catalyst Pharmaceuticals, Inc. $CPRXSeptember 2 at 5:05 AM | marketbeat.comAlphaQuest LLC Sells 35,327 Shares of Catalyst Pharmaceuticals, Inc. $CPRXSeptember 2 at 4:20 AM | marketbeat.comRaymond James Financial Inc. Has $10.68 Million Position in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 2 at 3:53 AM | marketbeat.comNorthern Trust Corp Has $36.04 Million Holdings in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 1 at 3:51 AM | marketbeat.comCatalyst Pharmaceuticals President and CEO Trades $473K In Company StockAugust 29, 2025 | benzinga.comDirector At Catalyst Pharmaceuticals Sells $525K Of StockAugust 29, 2025 | benzinga.comInsider Selling: Catalyst Pharmaceuticals (NASDAQ:CPRX) CEO Sells 22,970 Shares of StockAugust 29, 2025 | insidertrades.comCatalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035August 29, 2025 | uk.finance.yahoo.comCatalyst Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 28, 2025 | globenewswire.comCapital Fund Management S.A. Sells 51,122 Shares of Catalyst Pharmaceuticals, Inc. $CPRXAugust 28, 2025 | marketbeat.comCresset Asset Management LLC Takes Position in Catalyst Pharmaceuticals, Inc. $CPRXAugust 28, 2025 | marketbeat.comAmerican Century Companies Inc. Has $12.77 Million Stock Position in Catalyst Pharmaceuticals, Inc. $CPRXAugust 28, 2025 | marketbeat.comVirtus Advisers LLC Buys New Holdings in Catalyst Pharmaceuticals, Inc. $CPRXAugust 27, 2025 | marketbeat.comMetLife Investment Management LLC Has $17.56 Million Holdings in Catalyst Pharmaceuticals, Inc. $CPRXAugust 27, 2025 | marketbeat.com95,079 Shares in Catalyst Pharmaceuticals, Inc. $CPRX Purchased by Campbell & CO Investment Adviser LLCAugust 27, 2025 | marketbeat.comUPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin PharmaceuticalsAugust 26, 2025 | globenewswire.comOliver Luxxe Assets LLC Purchases 36,280 Shares of Catalyst Pharmaceuticals, Inc. $CPRXAugust 26, 2025 | marketbeat.com181,390 Shares in Catalyst Pharmaceuticals, Inc. $CPRX Bought by Systematic Financial Management LPAugust 26, 2025 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Sells 102,510 Shares of Catalyst Pharmaceuticals, Inc. $CPRXAugust 26, 2025 | marketbeat.comRussell Investments Group Ltd. Trims Holdings in Catalyst Pharmaceuticals, Inc. $CPRXAugust 26, 2025 | marketbeat.comHighTower Advisors LLC Purchases Shares of 81,340 Catalyst Pharmaceuticals, Inc. $CPRXAugust 26, 2025 | marketbeat.comCatalyst Pharmaceuticals announces settlement of FIRDAPSE patent litigationAugust 25, 2025 | msn.comCatalyst Pharmaceuticals settles lawsuit with LupinAugust 25, 2025 | msn.comCatalyst Pharmaceuticals and SERB Settle Patent Litigation with Lupin Regarding FIRDAPSE®August 25, 2025 | quiverquant.comQCatalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin PharmaceuticalsAugust 25, 2025 | globenewswire.comEntryPoint Capital LLC Takes Position in Catalyst Pharmaceuticals, Inc. $CPRXAugust 25, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Lowered to Hold Rating by Zacks ResearchAugust 23, 2025 | marketbeat.comNuveen LLC Purchases New Position in Catalyst Pharmaceuticals, Inc. $CPRXAugust 23, 2025 | marketbeat.comLPL Financial LLC Increases Position in Catalyst Pharmaceuticals, Inc. $CPRXAugust 23, 2025 | marketbeat.comInvesco Ltd. Has $29.09 Million Position in Catalyst Pharmaceuticals, Inc. $CPRXAugust 22, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 79,846 Shares of Catalyst Pharmaceuticals, Inc. $CPRXAugust 22, 2025 | marketbeat.comVanguard Group Inc. Buys 64,486 Shares of Catalyst Pharmaceuticals, Inc. $CPRXAugust 22, 2025 | marketbeat.comAberdeen Group plc Raises Stake in Catalyst Pharmaceuticals, Inc. $CPRXAugust 20, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Deutsche Bank AGAugust 19, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Boston PartnersAugust 17, 2025 | marketbeat.comFox Run Management L.L.C. Increases Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 16, 2025 | marketbeat.comPublic Sector Pension Investment Board Acquires 131,283 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 15, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Makes New $3.91 Million Investment in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 15, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Average Recommendation of "Buy" from AnalystsAugust 15, 2025 | marketbeat.comCatalyst Pharmaceuticals: A Developing Story That's Cheap EnoughAugust 12, 2025 | seekingalpha.comXTX Topco Ltd Sells 15,179 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 12, 2025 | marketbeat.comCetera Investment Advisers Has $1.41 Million Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 12, 2025 | marketbeat.comCatalyst Pharma (CPRX) Receives a Buy from Bank of America SecuritiesAugust 11, 2025 | theglobeandmail.comSierra Summit Advisors LLC Acquires New Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 10, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Cut to "Hold" at Wall Street ZenAugust 10, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Trading Down 10.4% - Here's WhyAugust 8, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comCatalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business UpdateAugust 6, 2025 | globenewswire.comLambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)August 6, 2025 | globenewswire.comThree Seasons Wealth LLC Buys Shares of 20,324 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)August 6, 2025 | marketbeat.com Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPRX Media Mentions By Week CPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPRX News Sentiment▼0.941.12▲Average Medical News Sentiment CPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPRX Articles This Week▼198▲CPRX Articles Average Week Get the Latest News and Ratings for CPRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Catalyst Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MRNA News VRNA News BBIO News ELAN News ROIV News GRFS News RVMD News RYTM News LEGN News ABVX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPRX) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPRX Stock Alerts